Shelia Ward faced the decision of turning off her husband’s life support after he showed signs of having a stroke
A woman has shared the heartbreaking moment she had to decide to turn off her husband’s life-support machine just 11 days after he received a Covid-19 vaccine. Stephen Ward was taken to the hospital 10 days after receiving the AstraZeneca Covid-19 vaccine in 2021, according to his wife.
The 57-year-old man, who lived in Newcastle-Under-Lyme, showed signs of having a stroke, including trouble speaking and weakness in his limbs. Mr Ward, who had been employed at the Co-op for 40 years, developed a blood clot, and doctors tried hard to save him.
However, the following day, his family was informed that the bleeding was too serious for him to recover. It eventually led to the decision to turn off his life support.
“Stephen was one of those people who would help anybody do anything,” his wife Sheila Ward told the Press Association. “If your car wouldn’t start in the morning he would help you, if you were unwell he would mow your grass, he was just one of those community-minded people.”
She went on: “We had both had Covid back in the November before the vaccines were rolled out, so from our point of view there was no urgency to take the vaccine. It was just the obvious choice really – to take the vaccine to protect loves ones, and like everyone else we wanted to get back to normal.” Mrs Ward had to wait for almost a year for a coroner to confirm that his death was a “result of complications of medical vaccination”.
Kate Scott also gave evidence to the UK Covid-19 Public Inquiry after her husband Jamie was left permanently disabled after having a reaction to the vaccine. The senior IT engineer was 44 when he had the AstraZeneca jab in April 2021, Mrs Scott said. Ten days after receiving the vaccine, she says he woke with a headache, vomiting and impaired speech and was taken to the hospital by ambulance, where he had multiple operations to treat a blood clot in his brain, she added.
The father of two boys was in a coma for four weeks and suffered with side effects including impaired speech, reduced cognition, memory and processing deficits, visual difficulties, concentration difficulties and fatigue. He received a payment under the Vaccine Damage Payment Scheme (VDPS) on the basis of the balance of probabilities that the vaccine caused his injuries.
Mrs Scott told the Press Association: “He is a warrior. I often say we are the luckiest unlucky people. He survived. He wasn’t supposed to – I was called in four or five times to be told that he wouldn’t make it through the night. We are incredibly lucky that he is alive and he is able to be in our lives with the children and have moments of joy.
“But it is very, very difficult. The lasting brain damage is the size of a credit card. He had to relearn to walk, talk, eat, and communicate. He’s got a hidden disability of brain damage, processing issues, he has lost peripheral vision in both eyes, he can’t split and divide his attention, he has got chronic fatigue. He has had over 300 medical appointments and just navigating life with a brain injury is difficult.”
Mrs Scott said that in his work as an IT engineer, Mr Scott spent his working life “problem solving and fixing things”. She added: “It’s very unlikely he will be able to work again.” She told the Inquiry: “His relationship with me and, mostly, his relationship with our children will never be the same again.”
Mrs Scott and Mrs Ward are members of Vaccine Injured and Bereaved UK (Vibuk). The group has been calling for reform of the Vaccine Damage Payment Scheme – which currently sees eligible people given a one-off payment of £120,000.
The calls have been echoed in the latest report from the pandemic probe, with Inquiry chairwoman Baroness Heather Hallett saying the scheme is “not sufficiently supportive” and requires “urgent reform”. The probe highlights how the vaccine response was a “success story”, and says that by March 2023, 475,000 lives had been saved by Covid-19 vaccines in England and Scotland.
But it acknowledges that there were “rare cases” of people suffering serious injury or death as a result of vaccination. Lady Hallett said: “Tragically, a number of people suffered harm as a result of having a vaccine. This was a small minority compared to the overall scale of the vaccination programme, but of no less importance to the individuals affected and their families.”
She recommended increasing the minimum payment, which was last revised in 2007, saying the current payment is “too low”. The payout should increase in line with inflation, the report says, which would mean it would now be in an ‘excess’ of £200,000, and this should rise with inflation.
Lady Hallett also calls for a “fairer system” for determining payment. She also called for regulatory bodies to have access to healthcare records for safety monitoring for new vaccines and therapeutics.
Reacting to the report, Mrs Scott added: “It is an uncomfortable truth, but vaccine injury and death are part of the pandemic story. Today’s recommendations somewhat recognises that reality. We welcome this as an important step towards fairness for those who suffered devastating consequences.”
Solicitor Terry Wilcox, of Hudgell Solicitors – which has represented some of the vaccine injured groups, said: “The Inquiry rightfully provided a platform for their stories to be heard, and what they are calling for is simple. They deserve acknowledgement of the impact on their lives, which for many has been life-changing illness and loss of loved ones, and changes made to ensure they are properly supported, and that lessons are learned for the future.”
A group of 48 claimants who have been seriously injured or bereaved as a result of a side-effect of the AstraZeneca Covid-19 vaccine are represented by Leigh Day partner Sarah Moore. “The Vaccine Damage Payment Scheme, in its current form, fails to provide timely or adequate support to those who have been seriously injured or bereaved due to vaccine side effects,” she said.
The AstraZeneca Covid-19 jab, also known as Vaxzevria, was withdrawn from the market in May 2024. In December 2020, the vaccine became the second Covid-19 jab to be approved for use in the UK and former prime minister Boris Johnson hailed it as a “triumph for British science”.
Vaccine makers agreed that it could be manufactured on a not-for-profit basis for the duration of the pandemic worldwide and in perpetuity for low- and middle-income countries. Billions of doses were created and made available across 183 countries. Estimates suggest that the rollout of the jab saved 6.3 million lives worldwide.
On April 7, 2021, the Medicines and Healthcare Products Regulatory Agency (MHRA) issued updated information on the “possible risk of extremely rare and unlikely to occur specific types of blood clots” following vaccination with the AstraZeneca jab. AstraZeneca said in a statement: “Our sympathy goes out to anyone who has lost loved ones or reported health problems. Patient safety is our highest priority.
“From the body of evidence in clinical trials and real-world data, the Oxford-AstraZeneca vaccine has continuously been shown to have an acceptable safety profile and regulators around the world consistently state that the benefits of vaccination outweigh the risks of extremely rare potential side effects.
“We are incredibly proud of the role the Oxford-AstraZeneca played in ending the global pandemic. According to independent estimates, over six million lives were saved in the first year of use alone and over three billion doses were supplied globally. Our efforts have been recognised by governments around the world and are widely regarded as being a critical component of ending the global pandemic.”
You must be logged in to post a comment Login